Is Immunovia AB (publ) (0G8X.L) a Buy, Sell, or Hold?
Immunovia AB (publ)
LSE:0G8X.L
$0.695 SEK
-$0.7 (-50.36%)
- Volume
- 1.22M
- Average Volume
- 21.02K
- Market Capitalization
- $110.65M
- P/E Ratio
- -0.33
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $7.83
- Year Low
- $0.70
- Payout Ratio
- $0.00
- Current Ratio
- $1.10
Industry, Sector & symbol
| Stock Exchange | London Stock Exchange |
| CEO | Mr. Jeff Borcherding |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | 0G8X.L |
| CUSIP | |
| CIK | |
| Web | https://www.immunovia.com |
| Phone | 46 4 62 75 60 00 |
| Currency | SEK |
| Employees | 10 |
| Country | SE |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.10 |
| Quick Ratio | 1.10 |
| Cash Ratio | 0.95 |
Sales & Book Value
| Annual Sales | $1.58M |
| Price / Sales | 125.03 |
| Cash Flow | -2.57 |
| Price / Cash Flow | -0.96 |
| Price / Book | 1.93 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-7.38 |
| Trailing P/E Ratio | -0.33 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-309.44M |
| Net Margin | -13120.79% |
| Pretax Margin | -13120.79% |
| Return on Equity | -207.71% |
| Return on Assets | -199.28% |
Financials Score
| AltmanZ Score | -30.73 |
| Piotroski Score | 4.00 |
| Working Capital | 3.8M |
| Total Assets | 58.27M |
| Ebit | -113.43M |
| Market Cap | 110.65M |
| Total Liabilities | 38.56M |
Poll Results
About Immunovia AB (publ) (LSE:0G8X.L) Stock
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden. ...
Frequently Asked Questions
-
What is the current Immunovia AB (publ) (0G8X.L) stock price?
-
Immunovia AB (publ)(LSE:0G8X.L) stock price is $0.695 in the last trading session. During the trading session, 0G8X.L stock reached the peak price of $7.825 while $0.695 was the lowest point it dropped to. The percentage change in 0G8X.L stock occurred in the recent session was --50.36% while the dollar amount for the price change in 0G8X.L stock was -$-0.7.
-
0G8X.L's industry and sector of operation?
-
The LSE listed 0G8X.L is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of 0G8X.L?
-
Mr. Jeff Borcherding | Global Chief Executive Officer & President
Ms. Karin Almqvist Liwendahl | Chief Financial Officer
Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs
|
| -
How many employees does 0G8X.L have?
-
Number of 0G8X.L employees currently stands at 10. 0G8X.L operates from Medicon Village, Lund, 223 63, SE.
-
Link for 0G8X.L official website?
-
Official Website of 0G8X.L is: https://www.immunovia.com
-
How do I contact 0G8X.L?
-
0G8X.L could be contacted at phone #46 4 62 75 60 00 and can also be accessed through its website. 0G8X.L operates from Medicon Village, Lund, 223 63, SE.
-
How many shares of 0G8X.L are traded daily?
-
The average number of 0G8X.L shares traded daily for last 3 months was 21.02K.
-
What is the market cap of 0G8X.L currently?
-
The market value of 0G8X.L currently stands at $110.65M with its latest stock price at $0.695